Insider · CIK 0001540188
Kenneth DiPietro
Files at CERE (Cerevel Therapeutics Holdings, Inc.). First filing Dec 21, 2023, latest Dec 27, 2023.
In brief
Kenneth DiPietro files SEC Form 4 as officer at CERE (Cerevel Therapeutics Holdings, Inc.). Since Dec 21, 2023, Kenneth DiPietro has reported 0 open-market buys worth $0 and 2 open-market sells worth $591k, the latest filed on Dec 27, 2023.
A track record needs three past buys with six months of prices behind them; Kenneth DiPietro has 0, so none is measured yet.
The newest scored trade: sold $332k of CERE on Dec 22, 2023, filed Dec 27, 2023, scored 35 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Cerevel Therapeutics Holdings, Inc. | $332k 8,000 shares | -24% | - | |
| 33Weak | Cerevel Therapeutics Holdings, Inc. | $259k 6,256 shares | -20% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 22, 2023 | Cerevel Therapeutics Holdings, Inc. | 8,000 0.00% of outstanding | $332k | Dec 22, 2023 | $259k |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | CERE Cerevel Therapeutics Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +63,905 | $0.00 | $0 | 63,905 | Jan 23, 2024 |
| Dec 22, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Common Stock | +8,000 | $3.50 | $28k | 32,663 | Dec 27, 2023 |
| Dec 22, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | SOpen-market sale Common Stock | -8,000 | $41.45 | $332k | 24,663 | Dec 27, 2023 |
| Dec 22, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -8,000 | $0.00 | $0 | 302,242 | Dec 27, 2023 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Common Stock | +13,913 | - | - | 30,919 | Dec 21, 2023 |
| Dec 20, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | SOpen-market sale Common Stock | -6,256 | $41.42 | $259k | 24,663 | Dec 21, 2023 |
| Dec 19, 2023 | CERE Cerevel Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,913 | $0.00 | $0 | 0 | Dec 21, 2023 |
Questions about Kenneth DiPietro
Answered from the filings on this page, as of the latest one.
Is Kenneth DiPietro buying or selling?
Not in the last 12 months. Kenneth DiPietro's latest open-market trade on SEC Form 4 was sold $332k of CERE on Dec 22, 2023.
How did Kenneth DiPietro's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenneth DiPietro has 0.
Where does Kenneth DiPietro file Form 4?
Kenneth DiPietro has filed Form 4 at CERE (Cerevel Therapeutics Holdings, Inc.) as Chief Human Resources Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.